These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1343345)

  • 1. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression.
    Iwao Y; Hibi T; Watanabe M; Takaishi H; Hosoda Y; Hayashi A; Ohara M; Ogata H; Aiso S; Toda K
    J Clin Lab Immunol; 1992; 38(1):15-27. PubMed ID: 1343345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphokine "inhibitor of DNA synthesis" (IDS) suppresses human T lymphocyte proliferation by an interleukin-2-independent mechanism.
    Reed JC; Jegasothy BV; Batra BK; Weidenfeld J; Smith DR; Nowell PC
    Lymphokine Res; 1986; 5(1):11-20. PubMed ID: 3484797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treponema denticola immunoinhibitory protein induces irreversible G1 arrest in activated human lymphocytes.
    Lee W; Pankoski L; Zekavat A; Shenker BJ
    Oral Microbiol Immunol; 2004 Jun; 19(3):144-9. PubMed ID: 15107064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
    Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
    J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of the serum immunosuppressive factor by monocytes in patients with Crohn's disease.
    Watanabe M; Hibi T; Iwao Y; Kanai T; Ohara M; Fujisawa T; Ogata H; Watanabe N; Asakura H; Aiso S
    J Clin Lab Immunol; 1989 Aug; 29(4):161-6. PubMed ID: 2637362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.
    Rigby WF; Noelle RJ; Krause K; Fanger MW
    J Immunol; 1985 Oct; 135(4):2279-86. PubMed ID: 2993410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive factor produced by a B cell line derived from an adult T cell leukemia patient.
    Mori N; Yamashita U; Tanaka Y; Nagata K; Nakata K; Oda S; Eto S
    Int J Hematol; 1992 Aug; 56(1):29-39. PubMed ID: 1391804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell early activation antigens expressed by peripheral lymphocytes in Crohn's disease.
    Fais S; Pallone F; Squarcia O; Boirivant M; Pozzilli P
    J Clin Lab Immunol; 1985 Feb; 16(2):75-6. PubMed ID: 2985788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
    Agnholt J; Kaltoft K
    Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle.
    Mudzinski SP
    Toxicol Appl Pharmacol; 1993 Apr; 119(2):166-74. PubMed ID: 8097600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease.
    Watanabe M; Tsuru S; Zinnaka Y; Yoshida T; Aiso S; Hibi T; Asakura H; Tsuchiya M
    J Clin Lab Immunol; 1985 May; 17(1):13-9. PubMed ID: 4045994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell matrix adhesion-related proteins VLA-1 and VLA-2: regulation of expression on T cells.
    Hemler ME; Jacobson JG
    J Immunol; 1987 May; 138(9):2941-8. PubMed ID: 3106495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells.
    Kakuta Y; Ueki N; Kinouchi Y; Negoro K; Endo K; Nomura E; Takagi S; Takahashi S; Shimosegawa T
    Hum Mol Genet; 2009 Mar; 18(6):1089-98. PubMed ID: 19124533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of cell-mediated immunity in patients with Crohn's disease.
    Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
    Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.